Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$1.90
-0.220 (-10.38%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.81 $2.52 Friday, 10th May 2024 CHRS stock ended at $1.90. This is 10.38% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 20.44% from a day low at $1.81 to a day high of $2.18.
90 days $1.81 $2.87
52 weeks $1.44 $5.63

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Mar 03, 2022 $11.79 $11.99 $11.39 $11.56 475 400
Mar 02, 2022 $11.61 $11.98 $11.50 $11.73 449 300
Mar 01, 2022 $11.68 $11.85 $11.37 $11.49 558 300
Feb 28, 2022 $11.55 $12.02 $11.54 $11.79 500 200
Feb 25, 2022 $11.50 $11.73 $11.10 $11.73 653 500
Feb 24, 2022 $10.63 $11.49 $10.53 $11.46 888 500
Feb 23, 2022 $11.13 $11.23 $10.75 $10.92 974 200
Feb 22, 2022 $12.16 $12.19 $10.95 $11.12 1 745 500
Feb 18, 2022 $12.36 $12.79 $11.64 $12.32 1 291 800
Feb 17, 2022 $13.07 $13.22 $12.85 $12.85 1 520 400
Feb 16, 2022 $13.09 $13.30 $12.75 $13.18 654 600
Feb 15, 2022 $13.13 $13.50 $13.07 $13.20 723 800
Feb 14, 2022 $12.91 $13.19 $12.81 $13.03 1 072 200
Feb 11, 2022 $12.61 $13.03 $12.46 $12.83 990 000
Feb 10, 2022 $12.16 $12.95 $11.94 $12.61 1 754 100
Feb 09, 2022 $12.43 $12.64 $12.37 $12.44 662 700
Feb 08, 2022 $11.74 $12.58 $11.54 $12.31 1 315 800
Feb 07, 2022 $12.20 $12.43 $11.24 $11.78 1 751 100
Feb 04, 2022 $12.04 $12.48 $11.99 $12.32 822 000
Feb 03, 2022 $12.40 $12.65 $12.06 $12.09 805 100
Feb 02, 2022 $12.63 $12.86 $12.38 $12.44 649 500
Feb 01, 2022 $12.38 $12.90 $12.12 $12.63 739 300
Jan 31, 2022 $11.92 $12.41 $11.86 $12.36 803 200
Jan 28, 2022 $11.43 $11.93 $11.13 $11.92 1 187 300
Jan 27, 2022 $12.05 $12.13 $11.44 $11.47 1 215 600
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT